The winner of this year’s MIT $100K Entrepreneurship Competition is helping advanced therapies reach more patients faster with a new kind of drug-injection device.

CoFlo Medical says its low-cost device can deliver biologic drugs more than 10 times faster than existing methods, accelerating the treatment of a range of conditions including cancers, autoimmune diseases, and infectious diseases.

“For patients battling these diseases, every hour matters,” said Simon Rufer SM ’22, who founded the company with Vishnu Jayaprakash PhD ’21 and MIT Professor Kripa Varanasi. “Biologic drugs are capable of treating some of the most challenging diseases, but their administration is unacceptably time-consuming, infringing on the freedom of the patient and effectively leaving them tethered to their hospital beds. The requirement of a hospital setting also makes biologics all but impossible in remote and low-access areas.”